Home » Topics » BioWorld Science

BioWorld Science
RSS

Enanta Pharmaceuticals describes new MAP3K5 inhibitors

Nov. 21, 2019

Rigel Pharmaceuticals synthesizes RIPK1 inhibitors

Nov. 21, 2019

Bristol-Myers Squibb discloses new UFO and MERTK inhibitors

Nov. 21, 2019

Eternity Bioscience patents RORC antagonists

Nov. 21, 2019

L-FABP levels correlated with sarcopenia measures in diabetic kidney disease

Nov. 21, 2019

Data on peripheral immune responses to selgantolimod from phase II study in HBV reported

Nov. 21, 2019

Truncated ACE2 fusion protein targets RAS overactivity in renal diseases

Nov. 21, 2019

Redox repositioning reaps benefits in TB treatment

Nov. 21, 2019

TLN1 gene mutations linked to human nephrotic syndrome

Nov. 21, 2019

Rat homologue of FX-201 decreases incidence and severity of osteoarthritis-related lesions

Nov. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...